Business Founder, Business Owner

Eric Lefkofsky Ensuring Better and Effective Cancer Treatment Through Tempus

Eric Lefkofsky is a well-known serial entrepreneur, author, technology enthusiast, and philanthropist based in the United States. Over the years, Eric Lefkofsky has co-founded many companies that have gone on to achieve great heights of success. One of the companies that he is most famously known for is Groupon Inc, which currently has the market valuation of over two billion. At one point in time, even Google offered to buy Groupon, but the offer was rejected due to various technical and legal issues. Other companies that he has co-founded include Echo Global Logistics, Uptake Technologies, Lightbank Investments, and MediaOcean.

One of the companies that Eric Lefkofsky recently co-founded is Tempus, which is a company that deals in gathering clinical, molecular, and genomic data for the treatment of cancer. When one of the loved one of Eric Lefkofsky was under treatment for a form of cancer, he realized that the doctors were not sure about the procedure being provided and there is a significant lack of clinical and molecular data aggregated at one source for the use of oncologists. It is how the idea to start Tempus came into his mind as he believes that technology has a more significant role to play in cancer treatment. Tempus would centralize the data it gathers for the use of oncologists from around the world. It would help the patients get personalized treatment that is necessary for faster recovery and the control of damage caused by cancer and read full article.

Eric Lefkofsky has started Tempus not with the aim of making money out of it but to make a difference in the cancer research field, which is lacking the data aggregation facility for so long. He believes that it is a roadblock that must be removed at the earliest to provide a ray of hope to the millions of people from across the globe suffering due to cancer. At the moment, the doctors have a very uniform approach towards treating cancer patients, and genomic data is not taken into the account when deciding the cancer treatment to be pursued. However, Tempus would help make the genomic data into consideration too, which would assist in providing effective cancer treatment and his Facebook.

More Visit: https://www.recode.net/2015/11/3/11620318/groupon-replaces-ceo-eric-lefkofsky-with-coo-rich-williams

Leave a Comment